STUDY OF SUBCUTANEOUS NITROGLYCERINE INFILTRATION FOR TRANS-RADIAL ACCESS IN IMPROVING THE SUCCESS RATE AND REDUCING EARLY RADIAL ARTERY BLOCKAGE

Evaluating the efficacy of subcutaneous nitroglycerine infiltration for trans radial access in improving the success rate and reducing early radial artery occlusion. A randomised double blind placebo controlled trial. - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070635

Enrollment

344

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Nitroglycerine: Subcutaneous injection during trans radial catheterisation Dose : 150 mcg Duration : injection will be given at the time of puncture as bolus Frequency: one dose Contr

Sponsors

JN Medical College AMU Aligarh

Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.giving written informed consent. 2.Patients undergoing diagnostic or therapeutic coronary catheterization via trans-radial approach

Exclusion criteria

Exclusion criteria: 1. Patients with inadequate blood supply to hand (negative Allen test) 2. Hemodynamic instability 3. Peripheral arterial disease 4. Raynauds phenomenon 5. Single Hand

Design outcomes

Secondary

Measure	Time frame
1. Local complications 2. Vascular complicationsTimepoint: From procedure to 24 hours	—

Primary

Measure	Time frame
1. Improvement in success rate of Trans radial access with the use of subcutaneous nitroglycerine 2. Prevention of Early radial artery occlusion with the use of subcutaneous nitroglycerineTimepoint: From procedure to 24 hours	—

Countries

India

Contacts

Public ContactIshfaq Gulzar Bhat

J N Medical College, AMU , Aligarh (UP)

drmranwar@gmail.com8171386851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026